Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 (the COMBAT-COVID-19 Pilot Study)

NCT04363437 is registered in ClinicalTrials.gov with Maimonides Medical Center as lead sponsor.

NCT NCT04363437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04363437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 (the COMBAT-COVID-19 Pilot Study)
Lead sponsor
Maimonides Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
April 26, 2020
Completion date
July 31, 2020
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection